Miscellaneous Healthcare

Tsumura & Co.

2540

4540

<p>Tsumura & Co. has signed a contract to acquire shares of Yomeishu Seizo Co., Ltd., aligning with its long-term strategy, TSUMURA VISION “Cho-WA” 2031. This acquisition aims to enhance Tsumura's position in Kampo and traditional Chinese medicine, focusing on preventive healthcare and personalized well-being. The latest analyst rating for Tsumura's stock (JP:4540) is a Buy, with a price target of Yen4762.00. Tsumura operates in the pharmaceutical sector, emphasizing evidence-based treatments and a supportive corporate culture.</p>

Tsumura & Co.(4540.JP)

Tsumura Aligns Yomeishu Share Acquisition With Long-Term Kampo Healthcare Vision